隆基股份(601012.SH)漲超6% 盤中振幅達13.85%
格隆匯4月28日丨昨晚公佈業績的隆基股份盤初一度跌近7%至57.04元,目前股價回升漲超6%報65.53元,盤中振幅達13.85%,市值超3500億元。公司昨晚發佈業績顯示,2021年營收809.32億元,同比增48.27%;淨利潤90.86億元,同比增6.24%,不及市場預期;同時公佈2022年一季度淨利潤26.64億元,同比增6.46%。隆基股份表示,2022年計劃實現營收超過1000億元。此外,隆基股份證券簡稱擬變更為“隆基綠能”。還值得注意的是,隆基股份再度上調單晶硅片價格。分析人士稱,隆基股份近期持續上調硅片價格,公司一季度淨利僅增長6%,利潤空間或已達瓶頸。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.